The effect of a single dose of sublingual misoprostol on blood loss in total abdominal hysterectomy in patients with uterine myoma
Phase 2
Recruiting
- Conditions
- uterine myoma.Disorder of uterus NOS
- Registration Number
- IRCT2016122831635N1
- Lead Sponsor
- Vice chancellor for research, Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Patients who choose to be treated by TAH with BSO or without BSO; Their last delivery was 24 months ago or before.
Exclusion criteria: History of pelvic surgery; Severe heart or lung disease; Hematologic Disorders; Glaucoma; Asthma; liver disease; Endometriosis; Adnexal masses; history of myomectomy; Those who have taken GnRH agonist before surgery; allergy to misoprostol, Diastolic pressure above 100.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes of Hemoglobin. Timepoint: 24 hours after interventional. Method of measurement: complete blood count.
- Secondary Outcome Measures
Name Time Method Bleeding during surgery. Timepoint: during surgery. Method of measurement: The amount of blood inside the suction device , The gravity of bloody sponges.